Portfolio company
Positrigo
Switzerland · £5.5m raised
Raised
£5.5m
Latest stage
Series B
Rounds recorded
1
Backed by
2 investors
Sectors
About
Positrigo develops compact brain positron emission tomography scanners for hospitals and neurology clinics to diagnose neurodegenerative diseases like Alzheimer's.
SourceFunding history · 1
Similar companies
Bottneuro
Bottneuro develops personalized non-invasive brain stimulation headsets for patients with neurological conditions such as Alzheimer's disease to provide home-based therapy.
Optina Dx
The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
Cortirio
Cortirio develops portable brain imaging headsets that use infrared light to diagnose strokes and traumatic brain injuries at the point of care.
Pre Diagnostics
This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.
Wellumio
This company develops portable magnetic resonance brain scanners for emergency medical providers to diagnose acute strokes at the point of care.
